{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:23:59Z","timestamp":1790742239418,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The French Journal of Urology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.purol.2023.09.013","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T08:31:00Z","timestamp":1695889860000},"page":"102526","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["New protocol in the treatment of Peyronie's disease by combining platelet-rich plasma, percutaneous needle tunneling, and penile modeling: Preliminary results"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4593-8003","authenticated-orcid":false,"given":"M.","family":"Alshuaibi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.S.","family":"Zugail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Lombion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Beley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.purol.2023.09.013_bib0160","doi-asserted-by":"crossref","first-page":"e0150157","DOI":"10.1371\/journal.pone.0150157","article-title":"The prevalence of Peyronie's disease in the United States: a population-based study","volume":"11","author":"Stuntz","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.purol.2023.09.013_bib0165","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0022-5347(01)65359-X","article-title":"The anatomy of the tunica albuginea in the normal penis and Peyronie's disease","volume":"157","author":"Brock","year":"1997","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.purol.2023.09.013_bib0170","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/sj.ijir.3900877","article-title":"Clinical presentations of Peyronie's disease","volume":"14","author":"Pryor","year":"2002","journal-title":"Int J Impot Res"},{"issue":"1","key":"10.1016\/j.purol.2023.09.013_bib0175","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0022-5347(17)52751-2","article-title":"Identification of an inherited form of Peyronie's disease with autosomal dominant inheritance and association with Dupuytren's contracture and histocompatibility B7 cross-reacting antigens","volume":"128","author":"Nyberg","year":"1982","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.purol.2023.09.013_bib0180","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.dsx.2018.11.039","article-title":"The prevalence of Peyronie's disease in diabetic patients -2018- Yazd","volume":"13","author":"Askari","year":"2019","journal-title":"Diabetes Metab Syndr"},{"issue":"3","key":"10.1016\/j.purol.2023.09.013_bib0185","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/j.1743-6109.2009.01655.x","article-title":"Peyronie's disease following radical prostatectomy: incidence and predictors","volume":"7","author":"Tal","year":"2010","journal-title":"J Sex Med"},{"issue":"6","key":"10.1016\/j.purol.2023.09.013_bib0190","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0895-4356(98)00015-8","article-title":"A case-control study on risk factors for Peyronie's disease","volume":"51","author":"Carrieri","year":"1998","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"10.1016\/j.purol.2023.09.013_bib0195","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1159\/000049830","article-title":"Peyronie's disease: prevalence and association with cigarette smoking. A multicenter population-based study in men aged 50-69 years","volume":"40","author":"La Pera","year":"2001","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.purol.2023.09.013_bib0200","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5152\/tud.2018.87405","article-title":"Peyronie's disease surgery: surgical outcomes of 268 cases","volume":"44","author":"Kad\u0131o\u011flu","year":"2018","journal-title":"Turk J Urol"},{"issue":"5","key":"10.1016\/j.purol.2023.09.013_bib0205","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1590\/S1677-5538.IBJU.2015.0598","article-title":"A prospective, randomized, single - blind study comparing intraplaque injection of thiocolchicine and verapamil in Peyronie's Disease: a pilot study","volume":"42","author":"Toscano","year":"2016","journal-title":"Int Braz J Urol"},{"issue":"1","key":"10.1016\/j.purol.2023.09.013_bib0210","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.juro.2013.01.087","article-title":"Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies","volume":"190","author":"Gelbard","year":"2013","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.purol.2023.09.013_bib0215","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.purol.2020.03.002","article-title":"Les th\u00e9rapeutiques non chirurgicales de la maladie de Lapeyronie\u00a0: \u00e9tat des lieux des connaissances actuelles [Non-surgical management of Peyronie's disease: State of current knowledge]","volume":"30","author":"Abdessater","year":"2020","journal-title":"Prog Urol"},{"key":"10.1016\/j.purol.2023.09.013_bib0220","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/s41443-020-0271-3","article-title":"Collagenase clostridium histolyticum is no longer available in Europe: what does this mean for our patients with Peyronie's Disease?","volume":"33","author":"Ziegelmann","year":"2021","journal-title":"Int J Impot Res"},{"issue":"12","key":"10.1016\/j.purol.2023.09.013_bib0225","first-page":"1323","article-title":"PRP and MSCs on tenocytes artificial wound healing: an in vitro study comparing fresh and frozen PRP","volume":"33","author":"Veronesi","year":"2018","journal-title":"Histol Histopathol"},{"issue":"4","key":"10.1016\/j.purol.2023.09.013_bib0230","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/01.ASW.0000396302.05959.d3","article-title":"Use of platelet-rich plasma and hyaluronic acid in the loss of substance with bone exposure","volume":"24","author":"Cervelli","year":"2011","journal-title":"Adv Skin Wound Care"},{"issue":"4","key":"10.1016\/j.purol.2023.09.013_bib0235","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/ijir.2011.18","article-title":"The association between Peyronie's and Dupuytren's disease","volume":"23","author":"Nugteren","year":"2011","journal-title":"Int J Impot Res"},{"issue":"5","key":"10.1016\/j.purol.2023.09.013_bib0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhsa.2017.03.003","article-title":"Injectable collagenase versus percutaneous needle fasciotomy for dupuytren contracture in proximal interphalangeal joints: a randomized controlled trial","volume":"42","author":"Skov","year":"2017","journal-title":"J Hand Surg Am"},{"key":"10.1016\/j.purol.2023.09.013_bib0245","first-page":"16A","article-title":"Section percutan\u00e9e des plaques de La Peyronie \u00e0 l\u2019aiguille fine. \u00c0 propos de 13 cas","volume":"11","author":"Chaffange","year":"2001","journal-title":"Prog Urol"},{"issue":"6","key":"10.1016\/j.purol.2023.09.013_bib0250","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/bju.14784","article-title":"Optimizing collagenase Clostridium histolyticum therapy for Peyronie's disease using a novel approach with percutaneous needle tunnelling","volume":"124","author":"Fern\u00e1ndez-Pascual","year":"2019","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.purol.2023.09.013_bib0255","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/jsm.12731","article-title":"Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie's disease: a phase 3 open-label study","volume":"12","author":"Levine","year":"2015","journal-title":"J Sex Med"},{"issue":"8","key":"10.1016\/j.purol.2023.09.013_bib0260","doi-asserted-by":"crossref","first-page":"669","DOI":"10.56434\/j.arch.esp.urol.20227508.98","article-title":"Applications of platelet rich plasma in urology","volume":"75","author":"Y\u00e1\u00f1ez-Castillo","year":"2022","journal-title":"Arch Esp Urol"},{"issue":"11","key":"10.1016\/j.purol.2023.09.013_bib0265","first-page":"44","article-title":"Platelet-rich plasma: a comprehensive review of emerging applications in medical and aesthetic dermatology","volume":"14","author":"White","year":"2021","journal-title":"J Clin Aesthet Dermatol"},{"issue":"4","key":"10.1016\/j.purol.2023.09.013_bib0270","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41443-021-00482-z","article-title":"The potential of platelet-rich plasma injections and stem cell therapy for penile rejuvenation","volume":"34","author":"Israeli","year":"2022","journal-title":"Int J Impot Res"},{"issue":"1","key":"10.1016\/j.purol.2023.09.013_bib0275","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4111\/icu.2018.59.1.61","article-title":"Safety and feasibility of platelet rich fibrin matrix injections for treatment of common urologic conditions","volume":"59","author":"Matz","year":"2018","journal-title":"Investig Clin Urol"},{"issue":"2","key":"10.1016\/j.purol.2023.09.013_bib0280","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.sxmr.2020.12.004","article-title":"Platelet-rich plasma injections for erectile dysfunction and Peyronie's disease: a systematic review of evidence","volume":"10","author":"Alkandari","year":"2022","journal-title":"Sex Med Rev"},{"issue":"4","key":"10.1016\/j.purol.2023.09.013_bib0285","first-page":"586","article-title":"La technique de Leriche dans le traitement de la maladie de La Peyronie [Leriche technique for the treatment of La Peyronie's disease]","volume":"14","author":"Khouaja","year":"2004","journal-title":"Prog Urol"},{"issue":"1","key":"10.1016\/j.purol.2023.09.013_bib0290","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0022-5347(06)00517-9","article-title":"Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon alpha-2B for minimally invasive treatment for Peyronie's disease","volume":"176","author":"Hellstrom","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2023.09.013_bib0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15761\/SHI.1000102","article-title":"Evaluation of the benefit of using a combination of autologous platelet rich-plasma and hyaluronic acid for the treatment of Peyronie's disease","volume":"1","author":"Virag","year":"2017","journal-title":"Sex Health Issues"},{"issue":"5 Suppl. 2","key":"10.1016\/j.purol.2023.09.013_bib0300","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/j.jsxm.2019.03.225","article-title":"PO-01-083 platelet-rich plasma therapy of Peyronie's disease","volume":"16","author":"Notsek","year":"2019","journal-title":"J Sex Med"},{"key":"10.1016\/j.purol.2023.09.013_bib0305","series-title":"A picture of the penis: what your surgeon wants to know. Manchester: Trends in Urology and Men's Health [cited 2022 April 26]","author":"Micallef","year":"2020"},{"issue":"16","key":"10.1016\/j.purol.2023.09.013_bib0310","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.purol.2022.05.002","article-title":"Pilot study of intra-cavernous injections of platelet-rich plasma (P-shot\u00ae) in the treatment of vascular erectile dysfunction","volume":"32","author":"Schirmann","year":"2022","journal-title":"Prog Urol"}],"container-title":["The French Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708723002166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708723002166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T02:55:53Z","timestamp":1761188153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1166708723002166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S1166708723002166"],"URL":"https:\/\/doi.org\/10.1016\/j.purol.2023.09.013","relation":{},"ISSN":["2950-3930"],"issn-type":[{"value":"2950-3930","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New protocol in the treatment of Peyronie's disease by combining platelet-rich plasma, percutaneous needle tunneling, and penile modeling: Preliminary results","name":"articletitle","label":"Article Title"},{"value":"The French Journal of Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.purol.2023.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102526"}}